Infection with Human T-Cell Leukemia Virus Type I in Patients with Leukemia
Among 211 adults with leukemia who received multiple transfusions, 6 were found to be seropositive for human T-cell leukemia virus Type I (HTLV-I). Before the positive serum specimens were obtained, these patients received a mean of 14 units of red cells and 78 units of platelets. Seroconversion cou...
Saved in:
Published in | The New England journal of medicine Vol. 318; no. 4; pp. 219 - 222 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Boston, MA
Massachusetts Medical Society
28.01.1988
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Among 211 adults with leukemia who received multiple transfusions, 6 were found to be seropositive for human T-cell leukemia virus Type I (HTLV-I). Before the positive serum specimens were obtained, these patients received a mean of 14 units of red cells and 78 units of platelets. Seroconversion could be documented in three patients. None of the 6 patients seropositive for HTLV-I had a T-cell leukemia, other illnesses attributable to HTLV-I infection, or risk factors for HTLV-I infection other than transfusion: none were seropositive for human immunodeficiency virus. Patients with leukemia who receive multiple transfusions appear to be at risk for HTLV-I infection. (N Engl J Med 1988; 318: 219–22.)
HUMAN T-cell leukemia virus Type I (HTLV-I) has been associated primarily with adult T-cell leukemia. The virus is endemic in some areas of Japan,
1
2
3
the Caribbean,
4
5
6
7
8
Africa,
9
10
11
12
the southeastern United States,
13
and South America.
14
It is thought to be transmitted through sexual contact, from mother to fetus, through transfusion of infected blood products,
15
16
17
18
19
20
21
and by sharing of contaminated needles among drug abusers.
22
Patients with leukemia receive large quantities of blood products as part of their treatment. Evidence of infection in such patients may be a sensitive indicator of the prevalence of a variety of viruses in the blood-donor population. We . . . |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0028-4793 1533-4406 |
DOI: | 10.1056/NEJM198801283180405 |